Skip to main content
. 2021 Apr 20;16(17):1447–1454. doi: 10.4244/EIJ-D-20-01008

Table 3. Procedural outcome and procedure-related complications according to intervention groups.

Patients Surgery PMR n=14 ReClip PMR n=10 Surgery SMR n=13 ReClip SMR n=26 p-value
MR pre ReClip/surgery >2+, n (%) 14 (100) 10 (100) 13 (100) 26 (100) >0.999
MR post ReClip/surgery 0 1.5 [1-2]* 0 2 [1.5-2]* <0.001
TMVG post ReClip, mmHg / 4.0 [2.2-4.0]* / 3.8 [3.0-5.0]* 0.71
TAPSE post ReClip/surgery, mm 14±3 20±5 15±2 16±4 0.005
Duration until reintervention, months 1.3 [0.9-12]* 12 [2-19]* 0.4 [0.2-1.4]* 4 [0.8-13]* <0.001
Total LOS, days 17.0 [15.0-21.0]* 6.5 [4.5-14.5]* 11.0 [8.0-25.0]* 5.5 [4.0-7.8]* <0.001
Ventilation >48 hours, n (%) 4 (31) 1 (10) 6 (46) 1 (4) 0.005
Stroke 0 0 0 0 >0.999
Post acute kidney injury (yes), n (%) 2 (14) 1 (10) 3 (23) 2 (8) 0.597
Post-intervention blood transfusion (yes), n (%) 13 (93) 1 (10) 12 (92) 2 (8) <0.001
Intrahospital death, n (%) 0 1 (10) 5 (39) 3 (11) 0.036
Discharge status Home 4 (29) 6 (60) 2 (15) 21 (81) <0.001
Rehabilitation clinic 10 (71) 3 (30) 6 (46) 2 (8) <0.001
Numbers after frequencies are percentages. Stage II or III modified RIFLE criteria. *Median [IQR]. LOS: in-hospital length of stay after reintervention; TMVG: transmitral valve gradient